# Step8 Candidate One-Pagers (target=atherosclerosis)

## vm202
- Gate: **MAYBE** | Score: 61.8 | Endpoint: CV_EVENTS
- Unique supporting PMIDs: **3** | Harm sentences: 0
- Topic match ratio: None

### Mechanism hypotheses (auto)
- hgf
- ischemia

### Supporting evidence (top)
- PMID:39778757 | Evidence sentence from abstract (needs human interpretation).
- PMID:21703533 | Evidence sentence from abstract (needs human interpretation).
- PMID:33465273 | Evidence sentence from abstract (needs human interpretation).

### Negative / risk evidence (top)
- (none)

### Negative trials (CT.gov)
- NCT03363165 | PHASE2 | p=0.7586 | 

### Step9 next actions
- Define 2–3 primary readouts and stop/go thresholds (**HUMAN 必须设定**).
- Execute minimal in-vitro/ex-vivo validation (**HUMAN 执行**).
- Only then consider structure work if needed.

## medi6570
- Gate: **MAYBE** | Score: 67.0 | Endpoint: PLAQUE_IMAGING
- Unique supporting PMIDs: **2** | Harm sentences: 0
- Topic match ratio: None

### Mechanism hypotheses (auto)
- lox-1
- oxldl
- inflammation

### Supporting evidence (top)
- PMID:36688371 | Evidence sentence from abstract (needs human interpretation).
- PMID:36688371 | Evidence sentence from abstract (needs human interpretation).
- PMID:36688371 | Evidence sentence from abstract (needs human interpretation).
- PMID:40999229 | Evidence sentence from abstract (needs human interpretation).

### Negative / risk evidence (top)
- (none)

### Negative trials (CT.gov)
- NCT04610892 | PHASE2 | p=0.065, p=0.563, p=0.685 | 

### Step9 next actions
- Define 2–3 primary readouts and stop/go thresholds (**HUMAN 必须设定**).
- Execute minimal in-vitro/ex-vivo validation (**HUMAN 执行**).
- Only then consider structure work if needed.

## creatine monohydrate
- Gate: **MAYBE** | Score: 62.4 | Endpoint: PAD_FUNCTION
- Unique supporting PMIDs: **2** | Harm sentences: 0
- Topic match ratio: None

### Mechanism hypotheses (auto)
- inflammation

### Supporting evidence (top)
- PMID:27217930 | Evidence sentence from abstract (needs human interpretation).
- PMID:27217930 | Evidence sentence from abstract (needs human interpretation).
- PMID:21575742 | Evidence sentence from abstract (needs human interpretation).

### Negative / risk evidence (top)
- (none)

### Negative trials (CT.gov)
- NCT04471792 | PHASE2 | p=0.38 | 

### Step9 next actions
- Define 2–3 primary readouts and stop/go thresholds (**HUMAN 必须设定**).
- Execute minimal in-vitro/ex-vivo validation (**HUMAN 执行**).
- Only then consider structure work if needed.
